| 40.33 -0.22 (-0.54%) | 12-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 49.75 | 1-year : | 58.11 |
| Resists | First : | 42.59 | Second : | 49.75 |
| Pivot price | 40.72  |
|||
| Supports | First : | 36.79 |
Second : | 33.2 |
| MAs | MA(5) : | 40.8 |
MA(20) : | 39.64 |
| MA(100) : | 36.32 |
MA(250) : | 0 | |
| MACD | MACD : | 1.3 |
Signal : | 1.4 |
| %K %D | K(14,3) : | 59.4 |
D(3) : | 71.6 |
| RSI | RSI(14): 57.1 |
|||
| 52-week | High : | 43.11 | Low : | 28.29 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ ATRC ] has closed above bottom band by 37.9%. Bollinger Bands are 41% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 40.8 - 41.01 | 41.01 - 41.18 |
| Low: | 39.72 - 39.94 | 39.94 - 40.12 |
| Close: | 40.01 - 40.35 | 40.35 - 40.63 |
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
Wed, 24 Dec 2025
Has AtriCure (ATRC) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Wed, 24 Dec 2025
AtriCure (NASDAQ:ATRC) Stock Crosses Above Two Hundred Day Moving Average - Here's Why - MarketBeat
Wed, 24 Dec 2025
AtriCure Inc (NASDAQ:ATRC) Nasdaq Index Medical Device Depth - Kalkine Media
Mon, 22 Dec 2025
Analysts See an Over 26% Upside in AtriCure (ATRC) - Yahoo Finance
Sun, 21 Dec 2025
Assessing AtriCure (ATRC) Valuation After Milestone First‑in‑Human Results for Its Dual Energy Ablation Platform - Sahm
Fri, 19 Dec 2025
AtriCure (ATRC) Is Up 6.32% in One Week: What You Should Know - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 50 (M) |
| Shares Float | 48 (M) |
| Held by Insiders | 3.2 (%) |
| Held by Institutions | 99.6 (%) |
| Shares Short | 2,300 (K) |
| Shares Short P.Month | 2,300 (K) |
| EPS | -0.62 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 9.59 |
| Profit Margin | -5.6 % |
| Operating Margin | 0.1 % |
| Return on Assets (ttm) | -2.7 % |
| Return on Equity (ttm) | -6.2 % |
| Qtrly Rev. Growth | 15.8 % |
| Gross Profit (p.s.) | 7.8 |
| Sales Per Share | 10.42 |
| EBITDA (p.s.) | -0.13 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 43 (M) |
| Levered Free Cash Flow | 6 (M) |
| PE Ratio | -66.12 |
| PEG Ratio | 0 |
| Price to Book value | 4.2 |
| Price to Sales | 3.86 |
| Price to Cash Flow | 46.48 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|